Thrombolysis for acute ischaemic stroke: A new challenge for emergency medicine

Emergency Medicine Journal

Volumn 25, Issue 8, 2008, Pages 471-475

  Kendall, Jason ^a  

^a FRENCHAY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALTEPLASE; FIBRINOLYTIC AGENT; HEPARIN; PROUROKINASE; STREPTOKINASE; UROKINASE; WARFARIN;

ACUTE DISEASE; BLOOD CLOT LYSIS; CAUSE OF DEATH; CEREBROVASCULAR ACCIDENT; CLINICAL EDUCATION; CLINICAL PROTOCOL; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; DISABILITY; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; EMERGENCY MEDICINE; EMERGENCY WARD; FOLLOW UP; HUMAN; INTERNET; MORTALITY; POLITICS; PRIORITY JOURNAL; REVIEW; RISK BENEFIT ANALYSIS; SCORING SYSTEM; SYMPTOM; UNITED KINGDOM;

DELIVERY OF HEALTH CARE; EMERGENCY TREATMENT; GREAT BRITAIN; HEALTH POLICY; HUMANS; PRACTICE GUIDELINES AS TOPIC; STROKE; THROMBOLYTIC THERAPY;

EID: 49449090502     PISSN: 14720205     EISSN: None     Source Type: Journal    
DOI: 10.1136/emj.2007.054668     Document Type: Review

References (35)

1. Hudson J, Ross C, Taylor K. Joining forces to deliver improved stroke care. London: The National Audit Office, Press Office, 2007.
2. Boyle R. Mending hearts and brains. Clinical case for change. Report by Professor Roger Boyle, National Director for Heart Disease and Stroke. Department of Health, December 2006.
3. Department of Health. Institute for Innovation and Improvement. Delivering quality and value - focus on acute stroke. www.institute.nhs.uk (accessed September 2007).
4. Department of Health. A new ambition for stroke - a consultation on a national stroke strategy. www.dh.gov.uk/stroke (accessed July 2007).
5. Wardlaw JM, del Zoppo G, Yamaguchi T, et al. Thrombolysis for acute ischaemic stroke. Cochrane Database Syst Rev 2003;(3):CD000213. doi: 10.1002/14651858.CD000213.
6. Donnan GA, Davis SM, Chambers BR, et al. Streptokinase in acute ischaemic stroke: does time of therapy administration affect outcome? JAMA 1996;271:961-6.
7. Hommel M, Cornu C, Boutitie F, et al. Thrombolytic therapy with streptokinase in acute ischaemic stroke. N Engl J Med 1996; 335:145-50.
8. Candelise L, Aritzu E, Ciccone A, et al. Randomised controlled trial of streptokinase. aspirin, and combination of both in treatment of acute ischaemic stroke. Lancet 1995; 346:1509-14.
9. Morris AD, Ritchie C, Grosset DG, et al. A pilot study of streptokinase for acute cerebral infarction. Q J Med 1995; 88:727-31.
10. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group (NINDS). Tissue plasminogen activator for acute ischaemic stroke. N Engl J Med 1995;333:1581-7.
11. The European Cooperative Acute Stroke Study (ECASS). Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. JAMA 1995;274:1017-25.
12. Hacke W, Kaste M, Fieschi C, et al. Randomised double blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Lancet 1998; 352:1245-51.
13. Haley EC, Brott TG, Sheppard GL, et al. Pilot randomised trial of tissue plasminogen activator in acute ischaemic stroke. Stroke 1993;24:1000-4.
14. Mori E, Yoneda Y, Tabuchi M, et al. Intravenous recombinant tissue plasminogen activator in acute carotid artery territory stroke. Neurology 1992;42:976-82.
15. Clark WM, Albers GW, Madden KP, et al. The rt-PA (Alteplase) 0- to 6-hour Acute Stroke Trial, Part A. Results of a double-blind, placebo-controlled, multicentre study. Stroke 2000; 31:811-16.
16. Clark WM, Wissman S, Albers GW, et al. Recombinant tissue-type plasminogen activator (Alteplase) for ischaemic stroke 3 to 5 hours from symptom onset. The ATLANTIS Study: a randomised controlled trial. JAMA 1999;282:2019-26.
17. Abe T, Kazama M, Naito I, et al. Clinical evaluation for efficacy of tissue cultured urokinase (TCUK) on cerebral thrombosis by means of a multi-centre double blind study. Blood-Vessel 1981; 12:321-41.
18. Atarashi J, Ohtomo E, Araki G, et al. Clinical utility of urokinase in the treatment of acute stage cerebral thrombosis: multi-centre double-blind study in comparison with placebo. Clin Eval 1985;13:659-709.
19. Ohtomo E, Araki G, Itoh E, et al. Clinical efficacy of urokinase in the treatment of cerebral thrombosis. Multi-centre double-blind study in comparison with placebo. Clin Eval 1985; 15:711-31.
20. Chen Q, He M, for the Study Group of a 5 year National Project of the People's Republic of China (Chinese UK Study). Intravenous thrombolysis with urokinase for acute cerebral infarctions. Chin J Neurol 2002;35:210-13.
21. del Zoppo GJ, Higashida RT, Furlan AJ, et al. PROACT: a phase II randomised trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. Stroke 1998;29:4-11.
22. Furlan A, Higashida R, Weschler L, et al. Intraarterial pro-urokinase for acute ischaemic stroke. The PROACT II Study: a randomised controlled trial. JAMA 1999;282:2003-11.
23. von Kummer R, Allen KL, Holle R, et al. Acute stroke: usefulness of early CT findings before thrombolytic therapy. Radiology 1997;205:327-33.
24. Larrue V, von Kummer R, del Zoppo G, et al. Haemorrhagic transformation in acute ischaemic stroke: potential contributing factors in the European Cooperative Acute Stroke Study. Stroke 1997; 28:957-60.
25. Patel SC, Levine SR, Tilley BC, et al. National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Lack of clinical significance of early ischaemic changes on computerised tomography in acute stroke. JAMA 2001;286:2830-8.
26. Schriger DL, Kalafut M, Starkman S, et al. Cranial computerised tomography interpretation in acute stroke: physician accuracy in determining eligibility for thrombolytic therapy. JAMA 1998;279:1293-7.
27. Adams HP, del Zoppo G, Alberts MJ, et al. Guidelines for the early management of adults with ischaemic stroke: a guideline from the American Heart Association/American Stroke Association. Stroke 2007;38:1655-1711.
28. Audebert HJ, Kukla C, Clarmann, et al. Telemedicine for safe and extended use of thrombolysis in stroke: the Telemedic Pilot Project for Integrative Stroke Care (TEMPiS) in Bavaria. Stroke 2005;36:2018-20.
29. Krieger DW. Should a hospital without a neurologist use t-PA to treat stroke? Cleve Clin J Med 1999;66:585-6.
30. Morganstern LB, Lisabeth LD, Meccozzi AC, et al. A population-based study of acute stroke and TIA diagnosis. Neurology 2004;62:895-900.
31. The NINDS t-PA Sroke Study Group. Generalised efficacy of t-PA for acute stroke: subgroup analysis of the NINDS t-PA Stroke Trial. Stroke 1997;28:2119-25.
32. Qureshi AI, Kirmani JF, Sayed MA, et al. Buffalo Metropolitan Area and Erie County Stroke Study Group. Time to hospital arrival, use of thrombolytics, and in hospital oucomes in ischaemic stroke. Neurology 2005;64:2115-20.
33. Wahlgren N, Ahmed N, Davalos A, et al. Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke Monitoring Study (SITS-MOST): an observational study. Lancet 2007;369:275-82.
34. National Pre-hospital Guideline Group of the Royal College of Physicians. The recognition and emergency management of suspected stroke and TIA. Sudbury, Suffolk, UK; Lavenham Press Ltd. March 2007.
35. National Institute for Health and Clinical Excellence. Alteplase for the treatment of acute ischaemic stroke. Appraisal Guidance 122. London: NICE, June 2007.